Effect of dapagliflozin on cardiovascular outcomes in patients with type 2 diabetes according to baseline renal function and albuminuria status: Insights from DECLARE-TIMI 58



Zelniker, TA, Raz, I, Mosenzon, O, Dwyer, JP, Heerspink, HJL, Cahn, A, Im, K, Bhatt, DL, Leiter, LA, McGuire, DK
et al (show 5 more authors) (2019) Effect of dapagliflozin on cardiovascular outcomes in patients with type 2 diabetes according to baseline renal function and albuminuria status: Insights from DECLARE-TIMI 58. .

[img] Text
Zelniker ESC abstract DECLARE renal 2019.docx - Accepted Version

Download (69kB)
Item Type: Conference or Workshop Item (Unspecified)
Depositing User: Symplectic Admin
Date Deposited: 02 Jun 2020 08:05
Last Modified: 29 May 2021 01:11
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3089266